Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

163 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Association between treatment-related lymphopenia and survival in glioblastoma patients following postoperative chemoradiotherapy.
Mapelli R, Julita C, Bianchi SP, Gallina N, Lucchini R, Midulla M, Puci F, Saddi J, Trivellato S, Panizza D, De Ponti E, Arcangeli S. Mapelli R, et al. Among authors: arcangeli s. Strahlenther Onkol. 2022 May;198(5):448-457. doi: 10.1007/s00066-021-01855-5. Epub 2021 Oct 6. Strahlenther Onkol. 2022. PMID: 34617129 Free PMC article.
Survival and toxicity of weekly cisplatin chemoradiotherapy versus three-weekly cisplatin chemoradiotherapy for head and neck cancer: A systematic review and meta-analysis endorsed by the Italian Association of Radiotherapy and Clinical Oncology (AIRO).
De Felice F, Belgioia L, Alterio D, Bonomo P, Maddalo M, Paiar F, Denaro N, Corvò R, Merlotti A, Bossi P, Pappagallo GL, D' Angelillo RM, Magrini SM, Arcangeli S. De Felice F, et al. Among authors: arcangeli s. Crit Rev Oncol Hematol. 2021 Jun;162:103345. doi: 10.1016/j.critrevonc.2021.103345. Epub 2021 Apr 29. Crit Rev Oncol Hematol. 2021. PMID: 33933569 Review.
Attitudes, practices and perspectives on imaging strategies in prostate cancer: a national cross-sectional survey involving expert radiation oncologists on behalf of AIRO (Italian association of radiotherapy and clinical oncology) GU group.
Lucchini R, Francolini G, Matrone F, Timon G, Franzese C, Marvaso G, Borghetti P, Nicosia L, Trodella LE, Vinciguerra A, Jereczek-Fossa BA, Arcangeli S. Lucchini R, et al. Among authors: arcangeli s. Med Oncol. 2021 Nov 5;39(1):3. doi: 10.1007/s12032-021-01597-5. Med Oncol. 2021. PMID: 34739613
Rationale and Design of a Single-Arm, Phase 2, Multi-Center Study of Chemo-Immunotherapy Followed by Hypo-Fractionated RT and Maintenance Immunotherapy in Patients With Unresectable Stage III NSCLC: The DEDALUS Trial.
Filippi AR, Agustoni F, Arcangeli S, Cortinovis D, Ferrari A, Cicognini D, Saddi J, Klersy C, Pedrazzoli P, Malapelle U, Grossi F. Filippi AR, et al. Among authors: arcangeli s. Clin Lung Cancer. 2023 May;24(3):e122-e125. doi: 10.1016/j.cllc.2022.12.015. Epub 2023 Jan 20. Clin Lung Cancer. 2023. PMID: 36759266 Clinical Trial.
163 results